Alzheimer Treatment News

Roche Alzheimer’s antibody fails to slow cognitive decline in major test

WEDNESDAY, JULY 22, 2020 - Stephanie Knapik, a research associate, works at C2N Diagnostics in the Center for Emerging Technologies in St. Louis, Mo. Photo by Jerry Naunheim Jr.
View Content